2001
DOI: 10.1016/s0165-2427(01)00314-2
|View full text |Cite
|
Sign up to set email alerts
|

The ACVD task force on canine atopic dermatitis (XX): glucocorticoid pharmacotherapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
53
0
1

Year Published

2003
2003
2021
2021

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 47 publications
(54 citation statements)
references
References 15 publications
0
53
0
1
Order By: Relevance
“…Glucocorticoids are the most commonly used drugs for treating a variety of inflammatory skin diseases including CAD [28]. However, the adverse effects of glucocorticoids such as skin atrophy and iatrogenic Cushing's syndrome has limited the use of these compounds [2].…”
Section: Introductionmentioning
confidence: 99%
“…Glucocorticoids are the most commonly used drugs for treating a variety of inflammatory skin diseases including CAD [28]. However, the adverse effects of glucocorticoids such as skin atrophy and iatrogenic Cushing's syndrome has limited the use of these compounds [2].…”
Section: Introductionmentioning
confidence: 99%
“…The complex aetiopathogenesis of CAD is reflected in the individually tailored, combination therapeutic treatments often required for its effective management (Nuttall 2008). Strategies commonly employed include: allergen avoidance; allergen-specific immunotherapy ; antihistamine pharmacotherapy (DeBoer and ; antimicrobial therapy for secondary infections; essential fatty acids ; glucorticoid pharmacotherapy (Olivry and Sousa 2001a); and nonsteroidal antiinflammatory pharmacotherapy including immunosuppressive drugs (Marsella and Olivry 2001). Of these, glucorticoid steroids (GC) and cyclosporin A (CsA) were the most effective drugs available for the treatment of CAD (Olivry and Sousa 2001b).…”
Section: Introductionmentioning
confidence: 99%
“…This criterion further complicates the process for determining an optimal treatment regimen. For example, GC is associated with numerous detrimental side effects with the risk that its benefits may be outweighed by potential complications (Nuttall 2008;Olivry and Sousa 2001a). This is especially true for long-term treatment regimes.…”
Section: Introductionmentioning
confidence: 99%
“…Moreover, in dogs, current therapy commonly involves allergen-specific immunotherapy (Griffin and Hillier 2001) or symptomatic treatment with either corticosteroids (Olivry and Sousa 2001) or cyclosporin A (Olivry et al 2002). Neither one of these therapies is guaranteed successful or without side effects.…”
Section: Introductionmentioning
confidence: 99%